Patients survived a median 11.1 months after the diagnosis of brain metastases and a median 9.4 months from first SRS treatment, the researchers note. One-year survival was 47.7% and 2-year survival was 17.7%.

• 研究者说，诊断脑转移后的患者平均存活时间是11.；1月，接受一次SRS治疗的患者平均存活时间是9